Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine vs sufentanil for postoperative gastrointestinal recovery after laparoscopic colorectal cancer surgery
ChiCTR2200064753Phase 4Not yet recruiting
- Sponsor
- The Affiliated Hospital of Guangdong Medical University
- Start
- Nov 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in colorectal cancer (CRC) and postoperative ileus (POI) comparing Esketamine arm with Sufentanil arm (2 arms). Primary endpoint: Time of first postoperative anal exhaust. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
esketaminesufentanil
03
Conditions
colorectal cancer (CRC)postoperative ileus (POI)
Beyond the preview
Go deeper on ChiCTR2200064753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064753.